Cargando…

Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study

RATIONALE: Existing data on the effect of treatment of latent tuberculosis infection (LTBI) on T-cell responses to Mycobacterium tuberculosis (MTB)-specific antigens are contradictory. Differences in technical aspects of the assays used to detect this response and populations studied might explain s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goletti, Delia, Parracino, M Pasquale, Butera, Ornella, Bizzoni, Federica, Casetti, Rita, Dainotto, Duilio, Anzidei, Gianfranco, Nisii, Carla, Ippolito, Giuseppe, Poccia, Fabrizio, Girardi, Enrico
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794408/ https://www.ncbi.nlm.nih.gov/pubmed/17257436 http://dx.doi.org/10.1186/1465-9921-8-5

Ejemplares similares

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
por: Butera, Ornella, et al.
Publicado: (2009)

Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders
por: Delogu, Giovanni, et al.
Publicado: (2011)

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
por: Kabeer, Basirudeen Syed Ahamed, et al.
Publicado: (2011)

Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
por: Goletti, Delia, et al.
Publicado: (2008)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
por: Cannas, A, et al.
Publicado: (2019)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood
por: Chiacchio, Teresa, et al.
Publicado: (2011)

Does an Isoniazid Prophylaxis Register Improve Tuberculosis Contact Management in South African Children?
por: van Soelen, Nelda, et al.
Publicado: (2013)

Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia
por: Geremew, Demeke, et al.
Publicado: (2022)

A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
por: Philipose, Jobin, et al.
Publicado: (2022)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group
por: Melkie, Solomon Tibebu, et al.
Publicado: (2022)

Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study
por: Goletti, Delia, et al.
Publicado: (2008)

Correction: Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study
por: Goletti, Delia, et al.
Publicado: (2009)

Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency
por: Venditti, Carolina, et al.
Publicado: (2020)

Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
por: Taylor, Allan W., et al.
Publicado: (2013)

Isoniazid and alopecia
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2021)

Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Bari, Virginia, et al.
Publicado: (2022)

Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
por: Vita, Serena, et al.
Publicado: (2022)

Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2021)

Regrowth of Mycobacterium tuberculosis Populations Exposed to Antibiotic Combinations Is Due to the Presence of Isoniazid and Not Bacterial Growth Rate
por: Hendon-Dunn, Charlotte L., et al.
Publicado: (2019)

Isoniazid-induced alopecia
por: Gupta, K. B., et al.
Publicado: (2011)

Alopecia caused by isoniazid
por: Dixit, Ramakant, et al.
Publicado: (2014)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

Isoniazid metabolism and hepatotoxicity
por: Wang, Pengcheng, et al.
Publicado: (2016)

Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules
por: le Roux, Stanzi M, et al.
Publicado: (2009)

Empiric vs screening‐based use of isoniazid for tuberculosis prophylaxis: Safety and effectiveness in lung transplant recipients in Saudi Arabia
por: Korayem, Ghazwa B., et al.
Publicado: (2020)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Epidemiological and Molecular Investigation of the Heater–Cooler Unit (HCU)-Related Outbreak of Invasive Mycobacterium chimaera Infection Occurred in Italy
por: Cannas, Angela, et al.
Publicado: (2023)

Publisher Correction: Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
por: Lai, Edward Chia‑Cheng, et al.
Publicado: (2021)

Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids
por: Park, Jun Won, et al.
Publicado: (2020)

Ciao, ragazzi : 1o. corso audiovisivo d'italiano
por: Bizzoni, Franca
Publicado: (1980)

Isoniazid causing pleural effusion
por: Singh, S.K., et al.
Publicado: (2008)

Isoniazid- and ethambutol-induced psychosis
por: R., Prasad, et al.
Publicado: (2008)

Fatal poisoning by isoniazid and rifampicin
por: Sridhar, A., et al.
Publicado: (2012)

Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013)

Isoniazid-induced Immune Thrombocytopenia
por: Kuwabara, Gaku, et al.
Publicado: (2021)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qnu7fbgmohdo0kpsf6gjoff8eo